Jesús Vaquero
Jesús Vaquero has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Mercedes Zurita
Neuroscience Research Unit, Puerta de Hierro Hospital, Majadahonda, Madrid, Spain
4 shared publications- Santiago Coca
Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alcalá de Henares, Spain
3 shared publications - Celia Bonilla
Neuroscience Research Unit, Puerta de Hierro Hospital, Majadahonda, Madrid, Spain
2 shared publications Concepción Aguayo
Neuroscience Research Unit, Puerta de Hierro Hospital, Majadahonda, Madrid, Spain
2 shared publicationsAinhoa Hernando Rubio
Department of Nephrology, Organización Sanitaria Integrada Barrualde Galdakao, Spain
1 shared publication- Alicia Rodríguez Fernández
Hospital Universitario Virgen Macarena, Seville, Spain
1 shared publication
Latest Publications
- 20 May 2019
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 26 (3) , 426
Regarding: “Homemade Device to Facilitate Percutaneous Venous Arterialization in Patients With No-Option Critical Limb Ischemia”
- 20 May 2019
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 26 (3) , 426
Regarding: “Homemade Device to Facilitate Percutaneous Venous Arterialization in Patients With No-Option Critical Limb Ischemia”
- 1 November 2014
- Published by Elsevier in Cytotherapy
- Vol. 16 (11) , 1501-1510
Is the subarachnoid administration of mesenchymal stromal cells a useful strategy to treat chronic brain damage?
- 1 November 2014
- Published by Elsevier in Cytotherapy
- Vol. 16 (11) , 1501-1510
Is the subarachnoid administration of mesenchymal stromal cells a useful strategy to treat chronic brain damage?
- 22 October 2013
- Published by Wiley in Clinical Transplantation
- Vol. 27 (6) , 968-971
Cell transplantation in paraplegic patients: the importance of properly assessing the spinal cord morphology
Introduction: Cell transplantation in paraplegic patients is beginning, but scarce attention is paid to the morphology of lesions.Material and Methods: We studied using magnetic resonance imaging (MRI) the morphology of the injured spinal cord in 200 patients with chronic and complete paraplegia after spinal cord injury (SCI) at the thoracic level.Results: When it was possible to undertake a correct study of the lesion, approximately 35% of patients had images showing spinal cord transection or showed fine tracts of tissue that connected both edges of a virtually transected spinal cord. Approximately 30% of patients had significant kyphosis with chronic spinal cord compression, and approximately 5% of cases had extensive spinal cord atrophy. In only approximately 30% of the patients, MRI revealed a centromedullary cavity, which was generally limited to the level of the vertebral fracture, and failed to show any apparent spinal cord transection.Conclusions: Humans suffering from chronically established paraplegia show a great variability of lesions, which differs from the standardized images of SCI obtained in animal models. When we design clinical trials, our goal should be to achieve a correct selection of patients, and the morphology of the spinal cord must be one of the main factors to consider.
- 22 October 2013
- Published by Wiley in Clinical Transplantation
- Vol. 27 (6) , 968-971
Cell transplantation in paraplegic patients: the importance of properly assessing the spinal cord morphology
Introduction: Cell transplantation in paraplegic patients is beginning, but scarce attention is paid to the morphology of lesions.Material and Methods: We studied using magnetic resonance imaging (MRI) the morphology of the injured spinal cord in 200 patients with chronic and complete paraplegia after spinal cord injury (SCI) at the thoracic level.Results: When it was possible to undertake a correct study of the lesion, approximately 35% of patients had images showing spinal cord transection or showed fine tracts of tissue that connected both edges of a virtually transected spinal cord. Approximately 30% of patients had significant kyphosis with chronic spinal cord compression, and approximately 5% of cases had extensive spinal cord atrophy. In only approximately 30% of the patients, MRI revealed a centromedullary cavity, which was generally limited to the level of the vertebral fracture, and failed to show any apparent spinal cord transection.Conclusions: Humans suffering from chronically established paraplegia show a great variability of lesions, which differs from the standardized images of SCI obtained in animal models. When we design clinical trials, our goal should be to achieve a correct selection of patients, and the morphology of the spinal cord must be one of the main factors to consider.
- 1 May 2012
- Published by Wolters Kluwer Health
- Vol. 72 (5) , 1203-1212
The severity of brain damage determines bone marrow stromal cell therapy efficacy in a traumatic brain injury model
Patients who survive traumatic brain injury (TBI) can undergo serious sensorial and motor function deficits. Once damage occurs, there is no effective treatment to bring patients to full recovery. Recent studies, however, show bone marrow stromal cells (BMSC) as a potential therapy for TBI. This study was designed to determine whether the degree of neurologic deficits influences the efficacy of cell therapy using intracerebral transplantation of BMSC in an experimental model of chronically established TBI. Adult Wistar rats were subjected to weight-drop impact causing TBI. Two months later, the animals were classified according to levels of neurologic deficits. To achieve this, we used two different functional tests: the modified Neurologic Severity Score test and internal zone Permanence Time in Video-Tracking-Box analysis. Saline only or saline containing BMSC was injected into injured brain tissue of the animals that were classified having moderate or severe neurologic damage depending on the level of established functional deficits. All experimental groups were evaluated in the course of the following 2 months to study the efficacy of BMSC administration. The animals were then killed and their brains were studied. Our results showed that significant functional improvement was seen when BMSC was injected into animals with moderate brain damage, but no significant improvement was found in animals with severe functional deficits when compared with controls. These findings suggest that the severity of neurologic damage may determine the potential effect of cell therapy when applied to chronically established TBI.
- 1 May 2012
- Published by Wolters Kluwer Health
- Vol. 72 (5) , 1203-1212
The severity of brain damage determines bone marrow stromal cell therapy efficacy in a traumatic brain injury model
Patients who survive traumatic brain injury (TBI) can undergo serious sensorial and motor function deficits. Once damage occurs, there is no effective treatment to bring patients to full recovery. Recent studies, however, show bone marrow stromal cells (BMSC) as a potential therapy for TBI. This study was designed to determine whether the degree of neurologic deficits influences the efficacy of cell therapy using intracerebral transplantation of BMSC in an experimental model of chronically established TBI. Adult Wistar rats were subjected to weight-drop impact causing TBI. Two months later, the animals were classified according to levels of neurologic deficits. To achieve this, we used two different functional tests: the modified Neurologic Severity Score test and internal zone Permanence Time in Video-Tracking-Box analysis. Saline only or saline containing BMSC was injected into injured brain tissue of the animals that were classified having moderate or severe neurologic damage depending on the level of established functional deficits. All experimental groups were evaluated in the course of the following 2 months to study the efficacy of BMSC administration. The animals were then killed and their brains were studied. Our results showed that significant functional improvement was seen when BMSC was injected into animals with moderate brain damage, but no significant improvement was found in animals with severe functional deficits when compared with controls. These findings suggest that the severity of neurologic damage may determine the potential effect of cell therapy when applied to chronically established TBI.
- 1 January 2001
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 15 (3) , 247-250
Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas
The importance of angiogenesis as a prognostic factor in brain tumours has recently been reported. In this study, we analysed the long-term prognostic significance of a morphometric score expressing the endothelial area for every 1000 tumour cells, in tumour tissue from 26 patients with a low-grade oligodendroglioma that has been treated surgically and irradiated, and has a MIB-1 labelling index (MIB-1 LI) of less than 1%. In each tumour, a vascular endothelial surface index (VESI) was determined as the CD-34 immunostained endothelial area in w m2 per 1000 tumour cells. Patients with a VESI of less than 15 ( n = 12) showed a survival at 5 and 10 years of 100 and 71%, respectively, versus a survival of 50 and 0% for patients presenting a VESI greater than 15 ( n = 14); p < 0.05). Our present findings suggest the usefulness of VESI as a long-term prognostic pathological factor in low-grade oligodendroglioma.
- 1 January 2001
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 15 (3) , 247-250
Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas
The importance of angiogenesis as a prognostic factor in brain tumours has recently been reported. In this study, we analysed the long-term prognostic significance of a morphometric score expressing the endothelial area for every 1000 tumour cells, in tumour tissue from 26 patients with a low-grade oligodendroglioma that has been treated surgically and irradiated, and has a MIB-1 labelling index (MIB-1 LI) of less than 1%. In each tumour, a vascular endothelial surface index (VESI) was determined as the CD-34 immunostained endothelial area in w m2 per 1000 tumour cells. Patients with a VESI of less than 15 ( n = 12) showed a survival at 5 and 10 years of 100 and 71%, respectively, versus a survival of 50 and 0% for patients presenting a VESI greater than 15 ( n = 14); p < 0.05). Our present findings suggest the usefulness of VESI as a long-term prognostic pathological factor in low-grade oligodendroglioma.
- 1 October 1998
- Published by Elsevier in Cancer Letters
- Vol. 132 (1-2) , 213-217
Expression of vascular endothelial growth factor in cerebellar hemangioblastomas does not correlate with tumor angiogenesis
- 1 October 1998
- Published by Elsevier in Cancer Letters
- Vol. 132 (1-2) , 213-217
Expression of vascular endothelial growth factor in cerebellar hemangioblastomas does not correlate with tumor angiogenesis
- 1 October 1992
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 63 (2) , 176
Molecular and cytogenetic study of chromosomes #9 and #10 in malignant gliomas
- 1 October 1992
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 63 (2) , 176
Molecular and cytogenetic study of chromosomes #9 and #10 in malignant gliomas
- 1 April 1990
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 72 (4) , 616-618
Immunohistochemical study of natural killer cells in tumor-infiltrating lymphocytes of primary intracranial germinomas
✓ A monoclonal antibody against the surface marker IOT-10 of natural killer (NK) cells was used to investigate the presence and distribution of these cells in a series of nine primary intracranial germinomas. In all of these tumors, IOT-10-positive NK cells were found in small numbers, mainly distributed among the tumor cells. The data obtained in the present study suggest that the presence of NK cells in primary intracranial germinomas can be influenced by factors other than the mere quantity of tumor-infiltrating lymphocytes.
- 1 April 1990
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 72 (4) , 616-618
Immunohistochemical study of natural killer cells in tumor-infiltrating lymphocytes of primary intracranial germinomas
✓ A monoclonal antibody against the surface marker IOT-10 of natural killer (NK) cells was used to investigate the presence and distribution of these cells in a series of nine primary intracranial germinomas. In all of these tumors, IOT-10-positive NK cells were found in small numbers, mainly distributed among the tumor cells. The data obtained in the present study suggest that the presence of NK cells in primary intracranial germinomas can be influenced by factors other than the mere quantity of tumor-infiltrating lymphocytes.